Predictive biomarker of immune checkpoint inhibitors efficacy

Thierry Berghmans (Belgium), Luis Paz-Ares (Spain)

Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Number: 7

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Thierry Berghmans (Belgium), Luis Paz-Ares (Spain). Predictive biomarker of immune checkpoint inhibitors efficacy. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: